NCT04802343View on ClinicalTrials.gov

A Trial to Learn How BAY1817080 Moves Into, Through and Out of the Body and How Safe it is in Healthy Chinese Men

PHASE1CompletedINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

April 2, 2021

Primary Completion Date

July 19, 2021

Study Completion Date

October 29, 2021

Conditions
Healthy Volunteers
Interventions
DRUG

BAY1817080

Oral, tablet.

DRUG

Placebo

Oral, tablet.

Trial Locations (1)

200032

Zhongshan Hospital, Fudan University, Shanghai

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
lead

Bayer

INDUSTRY